ARS Pharmaceuticals Inc — Balance Sheet (NASDAQ:SPRY) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 333.47 M281.44 M233.19 M351.15 M327.65 M Total liabilities 19.65 M8.55 M2.43 M94.36 M213.39 M Total equity 313.81 M272.89 M230.76 M256.8 M114.26 M Total liabilities & shareholders' equities 333.47 M281.44 M233.19 M351.15 M327.65 M Total debt 5.85 M0——96.37 M Net debt -248.2 M-274.38 M——-148.61 M

뉴스

ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)

린크, ARS 제약 목표 주가 상향…매출 확대 전망

Leerink raises ARS Pharmaceuticals stock price target on sales expansion

ARS Pharmaceuticals, 4분기 전망치 상회…주가 상승

Earnings call transcript: ARS Pharmaceuticals beats Q4 2025 forecasts, stock rises

ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript

ARS Pharmaceuticals Q1 실적, 수익 예상치를 넘어

ARS Pharmaceuticals earnings beat by $0.01, revenue topped estimates

ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates

Canadian Natural to Report Q4 Earnings: What's in the Offing?

ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

ARS 제약, Raymond James "강력 매수" 의견 유지